- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · May 13, 2025 | 109.41M sh |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $8.36M |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $9.32M |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $11.13M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $11.69M |
| Current Assets | Q2 2025 · Mar 31, 2025 | $32.47M |
| Current Assets | Q2 2025 · Sep 30, 2024 | $35.4M |
| Total Assets | Q2 2025 · Mar 31, 2025 | $61.77M |
| Total Assets | Q2 2025 · Sep 30, 2024 | $95.9M |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 108.77M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 109.34M sh |
| Capex | Q2 2025 · Mar 31, 2024 | $38K |
| Operating Cash Flow | Q2 2025 · Mar 31, 2024 | $423K |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $105.47M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $106.32M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $109.3M |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | −$0.01 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | −$0.02 |
| Sga Expense restated | Q2 2025 · Mar 31, 2024 | $9.56M |
| Sga Expense restated | Q2 2025 · Mar 31, 2024 | $19.74M |
| Net Income | Q2 2025 · Mar 31, 2024 | −$1.01M |
| Net Income | Q2 2025 · Mar 31, 2024 | −$2.56M |
| Net Income | Q2 2025 · Dec 31, 2023 | −$1.56M |
| Operating Income restated | Q2 2025 · Mar 31, 2024 | −$1.95M |
| Operating Income restated | Q2 2025 · Mar 31, 2024 | −$3.59M |
| Gross Profit restated | Q2 2025 · Mar 31, 2024 | $8.39M |
| Gross Profit restated | Q2 2025 · Mar 31, 2024 | $17.73M |
| Cost Of Revenue restated | Q2 2025 · Mar 31, 2024 | $17.2M |
| Cost Of Revenue restated | Q2 2025 · Mar 31, 2024 | $36M |
| Revenue restated | Q2 2025 · Mar 31, 2024 | $25.59M |
| Revenue restated | Q2 2025 · Mar 31, 2024 | $53.73M |